A Roche Holding AG study of its experimental breast-cancer drug in combination with another treatment failed to meet the ...

For years, a protein inside our cells has quietly powered billions of dollars' worth of cancer drugs. Now a team of researchers have discovered that this workhorse protein, called cereblon, in ...

A Lafayette father's battle with stage 4 pancreatic cancer is taking a hopeful turn as he becomes the first in Colorado to receive a newly approved targeted therapy.

Identifying the mechanisms of action driving a drug’s anti-cancer efficacy is critical for identifying optimal biomarkers, indications, and combinations for clinical success. Yet, systematically ...

Researchers have successfully used repurposed cancer drugs to target dormant breast cancer cells, aiding in the delay or prevention of recurrence, according to a study published Sept. 2 in Nature ...

Antibody drug conjugates have cemented their place among the treatment options for many cancers, but one problem with this type of targeted therapy is drug resistance. The scientists at Fortitude ...

A group of natural compounds attracting attention for their anti-aging potential has a dark side. New research shows how a ...

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.